BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Triplette M, Justice A, Attia EF, Tate J, Brown ST, Goetz MB, Kim JW, Rodriguez-Barradas MC, Hoo GWS, Wongtrakool C, Akgün K, Crothers K. Markers of chronic obstructive pulmonary disease are associated with mortality in people living with HIV. AIDS 2018;32:487-93. [PMID: 29135579 DOI: 10.1097/QAD.0000000000001701] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 3.8] [Reference Citation Analysis]
Number Citing Articles
1 Singhvi D, Bon J, Morris A. Obstructive Lung Disease in HIV-Phenotypes and Pathogenesis. Curr HIV/AIDS Rep 2019;16:359-69. [PMID: 31256349 DOI: 10.1007/s11904-019-00456-3] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 6.5] [Reference Citation Analysis]
2 MacDonald DM, Zanotto AD, Collins G, Baker JV, Czarnecki M, Loiza E, Nixon DE, Papastamopoulos V, Wendt CH, Wood R, Kunisaki KM; INSIGHT START Pulmonary Substudy Group. Associations between baseline biomarkers and lung function in HIV-positive individuals. AIDS 2019;33:655-64. [PMID: 30601153 DOI: 10.1097/QAD.0000000000002101] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 3.3] [Reference Citation Analysis]
3 Costiniuk CT, Singer J, Langlois MA, Kulic I, Needham J, Burchell A, Jenabian MA, Walmsley S, Ostrowski M, Kovacs C, Tan D, Harris M, Hull M, Brumme Z, Brockman M, Margolese S, Mandarino E, Angel JB, Routy JP, Anis AH, Cooper C. CTN 328: immunogenicity outcomes in people living with HIV in Canada following vaccination for COVID-19 (HIV-COV): protocol for an observational cohort study. BMJ Open 2021;11:e054208. [PMID: 34916326 DOI: 10.1136/bmjopen-2021-054208] [Reference Citation Analysis]
4 van Riel SE, Klipstein-Grobusch K, Barth RE, Grobbee DE, Feldman C, Shaddock E, Stacey SL, Venter WDF, Vos AG. Predictors of impaired pulmonary function in people living with HIV in an urban African setting. South Afr J HIV Med 2021;22:1252. [PMID: 34522426 DOI: 10.4102/sajhivmed.v22i1.1252] [Reference Citation Analysis]
5 Kalmin MM, Westreich D, Drummond BM, Sun J, Mehta SH, Kirk GD. Incident obstructive lung disease and mortality among people with HIV and a history of injecting drugs. AIDS 2021;35:1451-60. [PMID: 33831913 DOI: 10.1097/QAD.0000000000002914] [Reference Citation Analysis]
6 Alexandrova Y, Costiniuk CT, Jenabian MA. Pulmonary Immune Dysregulation and Viral Persistence During HIV Infection. Front Immunol 2021;12:808722. [PMID: 35058937 DOI: 10.3389/fimmu.2021.808722] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Byanova K, Kunisaki KM, Vasquez J, Huang L. Chronic obstructive pulmonary disease in HIV. Expert Rev Respir Med 2021;15:71-87. [PMID: 33167728 DOI: 10.1080/17476348.2021.1848556] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
8 MacDonald DM, Melzer AC, Collins G, Avihingsanon A, Crothers K, Ingraham NE, Mugerwa H, Ristola M, Shuter J, Kunisaki KM; INSIGHT START Pulmonary Substudy Group. Smoking and Accelerated Lung Function Decline in HIV-Positive Individuals: A Secondary Analysis of the START Pulmonary Substudy. J Acquir Immune Defic Syndr 2018;79:e85-92. [PMID: 29985804 DOI: 10.1097/QAI.0000000000001797] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
9 Costiniuk CT, Salahuddin S, Farnos O, Olivenstein R, Pagliuzza A, Orlova M, Schurr E, De Castro C, Bourbeau J, Routy JP, Ancuta P, Chomont N, Jenabian MA. HIV persistence in mucosal CD4+ T cells within the lungs of adults receiving long-term suppressive antiretroviral therapy. AIDS 2018;32:2279-89. [PMID: 30102653 DOI: 10.1097/QAD.0000000000001962] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 5.8] [Reference Citation Analysis]
10 Yano C, Tominaga M, Naito Y, Tokunaga Y, Kinoshita T, Sasaki J, Okamoto M, Yaita K, Obara H, Kakuma T, Hoshino T, Kawayama T. Airway hyperresponsiveness and inflammation in Japanese patients with human immunodeficiency virus 1 infection. J Infect Chemother 2021:S1341-321X(21)00337-8. [PMID: 34933786 DOI: 10.1016/j.jiac.2021.12.001] [Reference Citation Analysis]
11 Gamble-George JC, Longenecker CT, Webel AR, Au DH, Brown AF, Bosworth H, Crothers K, Cunningham WE, Fiscella KA, Hamilton AB, Helfrich CD, Ladapo JA, Luque A, Tobin JN, Wyatt GE; Implementation Research to Develop Interventions for People Living with HIV (PRECluDE) Consortium. ImPlementation REsearCh to DEvelop Interventions for People Living with HIV (the PRECluDE consortium): Combatting chronic disease comorbidities in HIV populations through implementation research. Prog Cardiovasc Dis 2020;63:79-91. [PMID: 32199901 DOI: 10.1016/j.pcad.2020.03.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]